Taylor Wealth Management Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-51,201
Closed -$1.85M 69
2021
Q1
$1.85M Sell
51,201
-81,793
-62% -$2.9M 0.68% 45
2020
Q4
$4.9M Sell
132,994
-8,204
-6% -$301K 1.88% 19
2020
Q3
$4.92M Sell
141,198
-218
-0.2% -$7.64K 2.25% 15
2020
Q2
$4.39M Buy
+141,416
New +$4.8M 2.23% 18
2019
Q1
Sell
-448
Closed -$19K 97
2018
Q4
$19K Hold
448
0.01% 70
2018
Q3
$19K Buy
448
+127
+40% +$4.89K 0.01% 87
2018
Q2
$11K Hold
321
﹤0.01% 107
2018
Q1
$11K Sell
321
-2,551
-89% -$87.7K 0.01% 99
2017
Q4
$99K Hold
2,872
0.04% 81
2017
Q3
$97K Hold
2,872
0.04% 83
2017
Q2
$92K Sell
2,872
-190
-6% -$5.99K 0.04% 82
2017
Q1
$99K Hold
3,062
0.04% 82
2016
Q4
$94K Sell
3,062
-53
-2% -$1.62K 0.04% 80
2016
Q3
$100K Sell
3,115
-52
-2% -$1.74K 0.04% 72
2016
Q2
$106K Hold
3,167
0.04% 66
2016
Q1
$89K Buy
3,167
+474
+18% +$13.5K 0.04% 65
2015
Q4
$82K Buy
2,693
+111
+4% +$3.49K 0.04% 66
2015
Q3
$77K Sell
2,582
-685
-21% -$22K 0.04% 65
2015
Q2
$104K Buy
3,267
+2,160
+195% +$70.4K 0.03% 67
2015
Q1
$37K Buy
+1,107
New +$35.2K 0.01% 91

Other funds holding PFE

Taylor Wealth Management Partners's PFE Position: Q2 2021 in Review

Taylor Wealth Management Partners sold out of Pfizer (PFE) in Q2 2021, closing a stake of 51,201 shares — an estimated $1.85M sold.

Taylor Wealth Management Partners first reported a position in PFE in Q1 2015 and held it in 20 quarters. The position peaked at $4.92M in Q3 2020. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • Taylor Wealth Management Partners reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
  • Taylor Wealth Management Partners sold 51,201 Pfizer shares in Q2 2021, an estimated $1.85M.
  • Taylor Wealth Management Partners first reported a position in Pfizer in Q1 2015 and held it in 20 quarters.
  • Taylor Wealth Management Partners's Pfizer position peaked at $4.92M in Q3 2020.
  • 2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2021, filed 11 Aug 2021.